Fecal microbiota transplants help patients with advanced melanoma respond to immunotherapy
Study is one of the first to demonstrate in patients that altering the composition of the gut microbiome can improve the response to immunotherapy.
Source: National Institutes of Health (NIH) News Releases - Category: American Health Source Type: news
More News: American Health | Immunotherapy | Melanoma | National Institutes of Health (NIH) | Skin Cancer | Study | Transplants